REVIEWS
IMAJ | volume 26
Journal 2, February 2024
pages: 102-107
Artificial Intelligence in Cardiology
1 Beilinson Medical Center Innovation, Artificial Intelligence Center, Rabin Medical Center, Petah Tikva, Israel
2 Department of Cardiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel
3 Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4 Faculty of Computer Science, Reichman University, Herzliya, Israel
Summary
Artificial intelligence (AI) has emerged as a transformative group of technologies in the field of medicine. Specifically in cardiology, numerous applications have materialized, and these are developing exponentially. AI-based risk prediction models leverage machine learning algorithms and large datasets to probe multiple variables, aid in the identification of individuals at high risk for adverse events, facilitate early interventions, and enable personalized risk assessments. Unique algorithms analyze medical images, such as electrocardiograms, echocardiograms, and cardiac computed tomography scans to enable rapid detection of abnormalities and aid in the accurate identification of cardiac pathologies. AI has also shown promise in guiding treatment decisions during coronary catheterization. In addition, AI has revolutionized remote patient monitoring and disease management by means of wearable and implantable sensing technologies. In this review, we discussed the field of cardiovascular genetics and personalized medicine, where AI holds great promise. While the applications of AI in cardiology are promising, challenges such as data privacy, interpretability of the findings, and multiple matters regarding ethics need to be addressed. We presented a succinct overview of the applications of AI in cardiology, highlighting its potential to revolutionize risk prediction, diagnosis, treatment, and personalized patient care.